comparemela.com
Home
Live Updates
Bernhard Gebauer - Breaking News
Pages:
Bernhard Gebauer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Inari PEERLESS II RCT Will Compare FlowTriever Versus Anticoagulation in PE Patients
May 22, 2023—Inari Medical, Inc. announced the planned enrollment of PEERLESS II, the company’s third randomized controlled trial (RCT) in
Thomas jefferson university
United states
Nordrhein westfalen
University of pennsylvania
Bernhard gebauer
Thomas tu
Felix mahfoud
Ajay giri
Inari flowtriever
University hospital charit
Department of internal medicine
University hospital saarland
Hospital of the university pennsylvania
Inari medical inc
Inari medical
Global principal investigators jay giri
vimarsana © 2020. All Rights Reserved.